X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Strides Arcolab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs STRIDES SHASUN LTD - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS STRIDES SHASUN LTD NOVARTIS/
STRIDES SHASUN LTD
 
P/E (TTM) x 269.1 34.3 784.5% View Chart
P/BV x 22.9 0.9 2,501.5% View Chart
Dividend Yield % 1.6 1.1 147.2%  

Financials

 NOVARTIS   STRIDES SHASUN LTD
EQUITY SHARE DATA
    NOVARTIS
Mar-17
STRIDES SHASUN LTD
Mar-17
NOVARTIS/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs8551,275 67.1%   
Low Rs666918 72.5%   
Sales per share (Unadj.) Rs219.0389.6 56.2%  
Earnings per share (Unadj.) Rs19.128.0 68.3%  
Cash flow per share (Unadj.) Rs20.348.9 41.5%  
Dividends per share (Unadj.) Rs10.004.50 222.2%  
Dividend yield (eoy) %1.30.4 320.4%  
Book value per share (Unadj.) Rs307.0303.1 101.3%  
Shares outstanding (eoy) m29.9689.42 33.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.52.8 123.3%   
Avg P/E ratio x39.839.2 101.6%  
P/CF ratio (eoy) x37.522.4 167.1%  
Price / Book Value ratio x2.53.6 68.5%  
Dividend payout %52.416.1 325.4%   
Avg Mkt Cap Rs m22,77998,036 23.2%   
No. of employees `0000.75.8 11.6%   
Total wages/salary Rs m1,3935,881 23.7%   
Avg. sales/employee Rs Th9,736.26,005.9 162.1%   
Avg. wages/employee Rs Th2,066.81,014.0 203.8%   
Avg. net profit/employee Rs Th849.0431.2 196.9%   
INCOME DATA
Net Sales Rs m6,56234,834 18.8%  
Other income Rs m7021,686 41.6%   
Total revenues Rs m7,26436,520 19.9%   
Gross profit Rs m2596,428 4.0%  
Depreciation Rs m361,872 1.9%   
Interest Rs m72,269 0.3%   
Profit before tax Rs m9173,973 23.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m345470 73.4%   
Profit after tax Rs m5722,501 22.9%  
Gross profit margin %3.918.5 21.4%  
Effective tax rate %37.611.8 318.0%   
Net profit margin %8.77.2 121.5%  
BALANCE SHEET DATA
Current assets Rs m9,73138,165 25.5%   
Current liabilities Rs m1,83030,402 6.0%   
Net working cap to sales %120.422.3 540.3%  
Current ratio x5.31.3 423.5%  
Inventory Days Days4977 63.0%  
Debtors Days Days25104 24.1%  
Net fixed assets Rs m5737,639 0.2%   
Share capital Rs m141894 15.7%   
"Free" reserves Rs m9,05626,210 34.6%   
Net worth Rs m9,19627,105 33.9%   
Long term debt Rs m016,377 0.0%   
Total assets Rs m11,49981,168 14.2%  
Interest coverage x128.42.8 4,667.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.60.4 133.0%   
Return on assets %5.05.9 85.7%  
Return on equity %6.29.2 67.4%  
Return on capital %10.112.1 83.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12913,465 1.0%   
Fx outflow Rs m1,7344,076 42.5%   
Net fx Rs m-1,6059,389 -17.1%   
CASH FLOW
From Operations Rs m-3802,881 -13.2%  
From Investments Rs m4,208-7,051 -59.7%  
From Financial Activity Rs m-3,3183,382 -98.1%  
Net Cashflow Rs m510-788 -64.8%  

Share Holding

Indian Promoters % 0.0 27.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 37.8 5.3%  
FIIs % 1.6 8.6 18.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.9 83.0%  
Shareholders   41,647 56,241 74.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  AUROBINDO PHARMA  

Compare NOVARTIS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 25, 2018 03:35 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - PLETHICO PHARMA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS